• Seth Crosby, MD
    Director Scientific Collaboration , Department of Genetics, Washington University School of Medicine
      Seth Crosby is the Director of Science Collaboration in the Department of Genetics at Washington University. Crosby works with groups within and outside the University to leverage technology to achieve research and clinical goals. He has been at Washington University for 16 years. During that time, he directed the Department of Genetics Microarray Core, which is now part of GTAC and then GTAC, itself, during its first two years. Prior to that he was the Director of Translational Research at the Genome Center (now the McDonnell Genome Institute). Prior to his tenure at Washington University, Dr. Crosby worked in the field of genomics and drug discovery at Abbott Laboratories, Pfizer and Pharmacia.
    • Garth Ehrlich, PhD, FAAAS
      Professor of Microbiology & Immunology, Professor of Otolarynology-Head and Neck Surgery, Drexel University College of Medicine
        Dr. Ehrlich is Professor of Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery at Drexel University College of Medicine (DUCoM) in Philadelphia, PA, USA. He also directs: the Center for Genomic Sciences (CGS); the Center for Advanced Microbial Processing (CAMP); and the Center for Surgical Infections and Biofilms within the Institute for Molecular Medicine and Infectious Disease at DUCoM. In addition, he directs the Core Genomics Facility for the Drexel University as a whole. CGS scientists utilize a broad array of comparative genomic techniques and bioinformatic tools, many developed in-house, to identify and characterize both virulence genes within pathogens, and susceptibility genes to pathogens within their hosts. Dr Ehrlich is also one of the founders of the field of Clinical Molecular Diagnostics (MDx), having been involved in the original application of PCR for the detection of human retroviruses in 19851. He founded the MDx Division at UPMC and used these experiences to author the first textbook/lab manual for infectious disease (ID) MDx2. Together with a team of like-minded pioneers he was one of the founders of the Association for Molecular Pathology and served as the first co-chair of the ID section. Dr Ehrlich counts among his major contributions to science the mapping and cloning of several major human disease genes3,4, and the re-writing of much of our understanding of chronic bacterial pathogenesis5,6. The latter began with his promulgation of the biofilm paradigm to explain many facets of chronic mucosal microbial infections7-9. Working with Chris Post, he started his explorations into chronic middle-ear disease in children in the early 90's which he has since repeatedly generalized such that it is now widely accepted that the vast majority of all chronic microbial infections are biofilm-associated10,11. He also advanced the Distributed Genome Hypothesis (DGH12,13) to explain the enormous clinical variability among strains of a bacterial species, which together with the biofilm paradigm form the bases for his rubric of Bacterial Plurality6. His work in human genetics combined with the laboratory resources necessary to test the DGH have resulted in his having played a role in the development of several waves of genomic technology over the last quarter century including microsatellite mapping, microarrays, and next-generation sequencing. More recently he has developed the concept of bacterial population-level virulence factors and has for the first time within the field of bacterial genomics used statistical genetics and machine learning algorithms approaches to identify unannotated distributed genes that are associated with virulence. These computational methodologies provides a non-biased, top-down approach to prioritize the annotation of hypothetical genes14. Coincident with the recent relocation of his research enterprise to DUCOM he founded CAMP which functions as a collaborative multi-discipline facility for exploitation of a suite of technological advances, many developed within the CGS, which permit the identification, cloning, heterologous expression, and biochemical verification of commercially important biosynthetic and biodegradative pathways from what he refers to as the "Genomic Dark Matter". This approach came out his successful collaborative studies with Dr. David Sherman at the University of Michigan wherein they used multiple omics technologies (and developed the term meta-omics) to isolate and characterize all of the genes for a novel biosynthetic pathway for an important anti-cancer drug from an unculturable endosymbiotic bacterium of a tunicate15. Over the past several years Dr Ehrlich has overseen the development of a novel ultra-high-fidelity microbiome assay that provides quantitative, species-specific analyses of microbial consortia using whole-gene 16S amplification and sequencing on the Pacific Biosciences third generation long-read sequencing platform16. When combined with a state-of-the art bioinformatics pipeline that takes advantage of novel pathway- algorithms and a custom database, developed in-house, this system provides unprecedented accuracy. In collaboration with Dr Curtis Harris at the NCI, Dr Ehrlich and his team applied this high-fidelity microbiome assay to identify bacterial species-specific changes to the lung microbiome associated with a specific TP-53 mutation - providing the first microbial biomarker for cancer17. Dr Ehrlich's lifelong interest in emergent MDx and "omic" technologies led to his recent appointment as Director of the Meta-Omics Core Facility at the Sidney Kimmel Cancer Center, a consortium NCI-designated Cancer Center involving Thomas Jefferson University and Drexel University. Dr Ehrlich's latest paradigm-changing hypothesis is that Alzheimer's disease results from a combination of chronic bacterial infections of the brain (primarily originating from the periodontium) and the brain's anti-microbial and inflammatory responses to these infections. Dr. Ehrlich was elected as fellow of the American Association for the Advancement of Science in 2014 and has won numerous awards for his research and teaching.
      • Jennifer Fettweis, PhD
        Assistant Professor & Director, Dept. of Microbiology & Immunology, Dept. of Obstetrics & Gynecology, Research Alliance for Microbiome Science Registry, Virginia Commonwealth University
          Jennifer M. Fettweis, Ph.D. is the founder and director of the Research Alliance for Microbiome Science (RAMS) Registry and assistant professor in the Departments of Microbiology and Immunology and Obstetrics and Gynecology at Virginia Commonwealth University. From 2009-2019, she served as the project director for two projects funded through the NIH's Human Microbiome Project: the Vaginal Human Microbiome Project (VaHMP) and the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI). Dr. Fettweis was awarded a B.A. in Mathematics and Economics from the University of Virginia and a Ph.D. in Microbiology and Immunology from Virginia Commonwealth University. As an international leader in the microbiome science, Dr. Fettweis studies how the microbiome impacts risk for pregnancy complications with a focus on the microbiome's influence on health disparities. She also investigates how human health is influenced by the transmission of the microbiome from mother to child and across generations.
        • Jonathan Galazka, PhD
          GeneLab Project Scientist, NASA Ames Research Center
            Dr. Jonathan Galazka is Project Scientist of the NASA GeneLab project at NASA Ames Research Center. Jonathan received a PhD in Molecular & Cell Biology from the University of California, Berkeley where he studied biomass degradation and conversion by filamentous fungi and yeasts. He performed a postdoctoral fellowship at Oregon State University where he studied the mechanisms of heterochromatin establishment, and the role of heterochromatin in maintaining genome structure. In addition to his work on GeneLab, Jonathan is developing synthetic biological solutions to NASA's technological needs.
          • Ann Palmenberg, PhD
            Roland Rueckert Professor, Biochemistry and Molecular Virology, UW-Madison
              Ann Palmenberg received her BS degree (Chemistry) from St. Lawrence University in 1970, and her PhD from the University of Wisconsin-Madison (Biochemistry, 1975), working in the laboratory of Paul Kaesberg. She received postdoctoral training with Charles Weissmann (Zurich) and Roland Rueckert (Madison). As the PI of a continuously funded (NIH) independent research program at the UW-Madison since 1978, Ann is now a Professor in the Department of Biochemistry and the Institute for Molecular Virology. Her work on the molecular biology of positive-sense RNA viruses, particularly picornaviruses in the cardiovirus and enterovirus (rhinovirus) genera, has achieved international stature for its breadth and content. She has expertise in computational modeling of protein:protein interactions, bioinformatics (sequence analysis), recombinant protein expression, protein purification, protein detection, enzyme assays (activity and complex formation ),and structural biology (crystallography, NMR, cryoEM). She has published extensively on these topics, both for research and technical audiences. She is an expert in RNA biochemistry, RNA dynamics, and RNA evolution. She teaches virology, bioinformatics and molecular modeling at the graduate and undergraduate levels.
            • Stacey Schultz-Cherry, PhD
              Full Member (Professor) Department of Infectious Diseases, St Jude Children's Research Hospital
                Dr. Schultz-Perry's introduction to influenza pathogenesis began as a postdoctoral fellow with Dr. Virginia Hinshaw at the University of Wisconsin. Given her PhD training as a cellular biochemist with an emphasis on wound healing and extracellular matrix-growth factor interactions in the Department of Pathology at the University of Alabama-Birmingham, her postdoctoral studies focused on understanding the viral and cellular factors involved in influenza virus-induced apoptosis. She was specifically interested in how highly pathogenic avian influenza (HPAI) viruses induced extensive damage. These studies led to a faculty position at the Southeast Poultry Research Lab (USDA-ARS) studying HPAI. The timing of the move corresponded to the 1997 HPAI outbreak in humans in Hong Kong. During her 5 years at the USDA, she was intimately involved in the H5N1 outbreak in terms of diagnostics, epidemiology, surveillance, and pathogenesis and worked closely with the CDC. They were also one of the first laboratories to begin working with turkey pneumovirus; closely related to human metapneumovirus. In 2002, she accepted a tenure-track faculty position at the University of Wisconsin School of Medicine and Public Health where her laboratory continued to focus on pathogenesis. She also identified and characterized a novel antiviral peptide that blocks influenza attachment. Their patent was recently licensed by a small influenza company. After receiving tenure at Wisconsin, St. Jude offered her a faculty position that she could not refuse. At St. Jude, her laboratory is part of the Center for Excellence in Influenza Research and Surveillance and the World Health Organization Collaborating Center. They are continuing with basic research studies but have also initiated surveillance efforts throughout Latin America.
              SEP 11 - 12 2019 Opens: 6:00 AM PDT
              Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

              Microbiology & Immunology 2019

              LabRoots and the Microbiology Planning Committee will bring the microbiology research community together at the 5th Annual Microbiology and Immunology Virtual Event! During the free, two-day event, participants will explore and discover new concepts, tools and techniques to apply to ongoing research and diagnostics. 

              Microbiology and Immunology cover an array of industries and disciplines, encompassing various research areas including pharmaceuticals, medicine, agriculture, and space. The development of new techniques and the ability to sequence organisms without the need to grow them in the laboratory has opened up a new world of microbial diversity and complexity we know little about. 

              The tracks for this years event include:

              • Earth and Human Management of Our Microbial Wealth
                • Metagenomics
                • Microbial Communities
                • Viromes
              • Emergency Diagnostics
              • New Methods and Emerging Trends
                • New Approaches to Vaccines
                • Antimicrobrial Resistance
              • New Insights into Virology
                • Virus-Host Interactions
                • Virus-Vector Interacations
                • Advances in Structural Virology

              Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

              Like the 2018 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots most


              Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2019 Microbiology and Immunology Virtual Event. Submission is free; submit your abstract here.  

              Continuing Education
              LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

              Use #LRmicro to follow the conversation! 


              • Director Scientific Collaboration , Department of Genetics, Washington University School of Medicine
              • Professor of Microbiology & Immunology, Professor of Otolarynology-Head and Neck Surgery, Drexel University College of Medicine
              • Assistant Professor & Director, Dept. of Microbiology & Immunology, Dept. of Obstetrics & Gynecology, Research Alliance for Microbiome Science Registry, Virginia Commonwealth University
              • GeneLab Project Scientist, NASA Ames Research Center
              • Roland Rueckert Professor, Biochemistry and Molecular Virology, UW-Madison
              • Full Member (Professor) Department of Infectious Diseases, St Jude Children's Research Hospital

              Show Resources
              You May Also Like
              MAR 27, 2019 06:00 AM PDT
              C.E. CREDITS
              MAR 27, 2019 06:00 AM PDT
              For the second year in a row, LabRoots is pleased to announce the 2019 Cannabis Sciences Virtual Event. LabRoots will host the 2nd annual event March 27-28, 2019.The Cannabis Sciences plannin...
              FEB 27, 2019 06:00 AM PST
              C.E. CREDITS
              FEB 27, 2019 06:00 AM PST
              After a hugely successful inaugural year, LabRoots and the Drug Discovery planning committee are pleased to announce the 2nd annual Drug Discovery Virtual conference. LabRoots will host the t...
              APR 25, 2019 06:00 AM PDT
              C.E. CREDITS
              APR 25, 2019 06:00 AM PDT
              In an effort to provide a platform to discuss leading scientific research on a range of topics, LabRoots has added another virtual event to the line up of conferences for 2019 – Infecti...
              MAR 13, 2019 06:00 AM PDT
              C.E. CREDITS
              MAR 13, 2019 06:00 AM PDT
              LabRoots is excited to present the 7th Annual premier Neuroscience virtual conference, to be broadcast live for free March 13-14, 2019. The 2019 planning committee has arrange speakers and pa...
              APR 10, 2019 06:00 AM PDT
              C.E. CREDITS
              APR 10, 2019 06:00 AM PDT
              LabRoots and the Molecular Diagnostics planning committee are excited to announce they will be hosting the 4th Annual Molecular Diagnostics Virtual Conference April 10-11, 2019. This premiere...
              FEB 13, 2019 06:00 AM PST
              C.E. CREDITS
              FEB 13, 2019 06:00 AM PST
              LabRoots, along with the Laboratory Animal Science (LAS) planning committee, are pleased announce the 8th annual Laboratory Animal Science virtual conference! LabRoots will host this two-day,...


              Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


              Enter the following information to this Submission Form:

              • Poster Title
              • Your Name
              • Your Institution
              • Your Email
              • Abstract describing the poster

              All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

              If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

              Questions? Email Posters@LabRoots.com

              LabRoots Policy

              Sponsored By

              For information on becoming a sponsor or exhibitor, please click here.

              C.E. Credits

              The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


              To download the Program Committee brochure here.

              • Emily Hollister

                Dr. Emily Hollister is a microbial ecologist and serves as the Vice President for Information Technology & Analytics at Diversigen, Inc. Prior to joining Diversigen, Dr. Hollister served as an Assistant Professor in the Department of Pathology & Immunology at Baylor College of ...

                See more See less
              • Ivan Brukner

                Dr Ivan Brukner entered into genomic era back in 1989 (ex-Yugoslavia), trying to describe and solve repeating sequence "branching motif problem" in building whole genome sequence. Next 5-10 years, his research was targeting sequence-dependent DNA structural problems, where ...

                See more See less
              • Philip Geis

                Philip A. Geis is a native Texan who earned bachelor and doctor of philosophy degrees in microbiology and mycology from The University of Texas. Between these efforts, he served in the US Army with final duty as clinical microbiologist for the Army's 45th field hospital APO ...

                See more See less
              • Jonas Korlach

                Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...

                See more See less
              • Neil Osheroff

                Neil Osheroff received a Bachelor's Degree in Chemistry from Hobart College in 1974 followed by a Ph.D. in Biochemistry and Molecular Biology from Northwestern University in 1979. His doctoral dissertation on the mechanism of action of cytochrome c was under the direction of ...

                See more See less
              • Marilyn Roossinck

                Dr. Roossinck received a PhD in 1986 from the University of Colorado School of Medicine in Microbiology and Immunology, studying Hepatitis B virus, on an National Institutes of Health fellowship. Following a postdoctoral fellowship at Cornell University, where she began studying ...

                See more See less
              • John Thomas

                Professor Emeritus John G. Thomas, PhD, is recognized as an "International Educator and Global Microbiologist " (www.globalbugs.com) having lectured in more than 43 countries while a clinical microbiologist in pathology (Professor), dentistry (Clinical Professor) and Graduate ...

                See more See less
              • Glenn Tillotson

                Glenn is a Senior Vice President at Cempra Inc in Chapel Hill, USA. He is trained in medical microbiology and infectious diseases and almost 30 of pharmaceutical industry experience in various areas including clinical research, commercialization, scientific communications ...

                See more See less

              General LabRoots Questions

              For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
              Contact us

              Virtual Events and Webinars

              Supported Configurations

              • Operating System Internet Explorer Firefox Chrome Safari
                Vista IE8+ FF10+ Chrome15+
                Windows 7 IE8+ FF10+ Chrome15+
                Windows 8 IE10 FF10+ Chrome15+
                Mac OS X   FF10+ Chrome15+ Safari5.1+
              • Cookie settings: session cookies enabled
              • Browser configuration must have JavaScript enabled
              • Adobe Flash player 10.2 or later

              To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

              Internet Connection

              • A minimum of 100Kbps is recommended for audio-only events
              • A minimum of 300Kbps is recommended for speaker on-video events

              Computer Equipment

              • Screen Resolution: Minimum 1024x768
              • Video Card: 65,000 colors minimum
              • Sound card and speakers (or headphones) for hearing webcast in full format
              • Audio Card: 16-bit minimum
              • RAM: 512MB of free RAM

              Firewall Protocol

              • HTTP on port 80 or HTTPS on port 443
              • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
              • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

              Work-At-Home Attendees

              • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

              For A Seamless Experience

              When using a mobile device, FREE Mobile Apps are available:

              - For viewing Webinars:

              - For viewing Virtual Events

              Attendee Guide

              • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

              Virtual Event and Webinar Support:

              Continuing Education (CME/CE) Support

              Loading Comments...
              Show Resources
              Event Countdown
              • 0 Days
              • 0 Hours
              • 0 Minutes
              • 0 Seconds